Technology & Innovation – Abbott
Abbott’s innovative technology is helping people of all ages living with diabetes live life to the fullest. Hear how it’s helping Michaela…
Know sooner. Act faster. Be ready to avoid low glucose with FreeStyle Libre Systems.
Libre 2 continuous glucose monitoring system16
The Libre 2 system is the #1 continuous glucose monitoring system used worldwide7. Here’s why:
• The small, discreet sensor is easily attached to the back of the upper arm3, where it continuously measures glucose levels.
• It can be used in those aged 2 and older17.
• It’s worn for up to 15 days and is water-resistant8, so it continues to work during exercise, swimming or showering.
• Excellent overall accuracy, even in the low glucose range when it matters the most.9
- Continuous glucose monitoring enables you to check glucose levels anytime10, anywhere8, even through clothing18.
- The display shows current glucose reading, 8-hour history and a trend arrow so you can take appropriate action.
- Optional glucose alarms can be set according to your needs to alert you when your glucose is too high or too low19.
Libre 3 System
As the worlds smallest*9, most discrete sensor yet, the Libre 3 sensors** continuously measure glucose levels, both day and night.10
Outstanding 15-day accuracy in paediatric patients9, helping improve overall glucose control2 and reduce the time spent in hypoglycaemia1,3.
Learn more about the Libre systems here.
All together, easier diabetes management through intentional partnerships.
The Libre 2 Plus sensor is authorised to work with the Omnipod® 5 Automated Insulin Delivery (AID) System. Our 15-day sensor and single-app setup process create one easy, integrated experience with Omnipod® 5.
Unlike other CGMs, there is no need to switch out a Libre 2 Plus sensor midway through an Omnipod® 5 use.20
The Libre 3 sensors also have AID integration. They are authorised to work with the mylife Loop21 Automated Insulin Delivery system. Minute-to-minute glucose readings combined with the mylife YpsoPump insulin pump and mylife CamAPS FX app – for easier22 diabetes management.
Get the most out of the Libre systems by connecting with the digital health solutions
Discover how the Libre products and digital health tools connect together here
Achieve better outcomes1-3
Management of diabetes has become more challenging over the last few years. To help people living with diabetes get access to the right technology, resources and information, the National Institute for Health and Care Excellence (NICE) has updated its guidance.
The latest guidelines address current inequalities in continuous glucose monitoring (CGM) by recommending wider access on the NHS for adults and children with type 1 diabetes and people with type 2 diabetes on insulin-intensive therapy who meet defined criteria.
• Adults with type 1 diabetes.4
• Children and young people with type 1 and type 2 diabetes.5
• People with type 2 diabetes on insulin-intensive therapy who meet defined criteria.6
You may wish to discuss these new guidelines with your diabetes team at your next appointment. However, it is important to remember that local areas are still working through their implementation.
Read more about the UK guidance here. Ireland has different guidance, which can be found here.
Visit our website FreeStyle.Abbott for more information and resources
Images are for illustrative purposes only. Not actual patient or data.
** – FreeStyle Libre3 sensors refer to FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors.
* – Among patient-applied sensors.
1. Bolinder, J. Lancet (2016): http://doi.org/10.1016/S0140-6736(16)31535-5.
2. Evans, M. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00720-0.
3. Haak, T., Diabetes Ther. (2017) : https://doi.org/10.1007/s13300-016-0223-6.
4. NICE guideline NG17 (2015) Last updated: 17th Aug 2022 , available at https://www.nice.org.uk/guidance/ng17.
5. NICE guideline NG18 (2015) Last updated 29th June 2022 available at https://www.nice.org.uk/guidance/ng18.
6. NICE NG28 (2015) Last updated 29th June 2022 available at: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-managementpdf-1837338615493.
7. Data on file, Abbott Diabetes Care, Inc. Based on the number of users worldwide for the FreeStyle Libre Portfolio compared to the number of users for other leading personal use sensor-based glucose monitoring systems.
8. Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
9. Data on file, Abbott Diabetes Care, Inc.
10. 60-minute warm-up required when applying the sensor.
11. Unger, J., Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
12. The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkUp.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
13. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.org.2019.0142
14. The FreeStyle Libre system apps are only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
15. The LibreView website is only compatible with certain operating systems and browsers. Please check www.LibreView.com for additional information.
16. FreeStyle Libre 2 flash glucose monitoring is a continuous glucose monitoring system.
17. For children aged 2-12, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre 2 system and interpreting its readings.
18. The reader can capture data from the sensor when it is within 1cm.
19. Notifications will only be received when alarms are turned on and the sensor is within 6 meters unobstructed of the reading device.
20. Based on up to 3 days of automated insulin delivery.
21. The FreeStyle Libre 3 and Libre 3 Plus sensor are authorised to work with the mylife Loop automated insulin delivery system, including the mylife CamAPS® FX app and mylife YpsoPump insulin pump. For use of the FreeStyle Libre 3 sensors with the mylife Loop, refer to the labeling provided with the mylife CamAPS FX app.
22. Based on product features including up to 14 & 15-day wear period, automatic readings every minute, accuracy data, and single-app setup with AID systems.
ADC-107139 V1.0 2/25